BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23292678)

  • 1. Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells.
    Daker M; Bhuvanendran S; Ahmad M; Takada K; Khoo AS
    Mol Med Rep; 2013 Mar; 7(3):731-41. PubMed ID: 23292678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma.
    Li Z; Duan Y; Cheng S; Chen Y; Hu Y; Zhang L; He J; Liao Q; Yang L; Sun LQ
    Oncotarget; 2015 Sep; 6(27):24291-303. PubMed ID: 26172457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
    Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M
    Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
    Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
    Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.
    Man CH; Wei-Man Lun S; Wai-Ying Hui J; To KF; Choy KW; Wing-Hung Chan A; Chow C; Tin-Yun Chung G; Tsao SW; Tak-Chun Yip T; Busson P; Lo KW
    J Pathol; 2012 Feb; 226(3):471-81. PubMed ID: 22009689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
    Baizig NM; Wided BA; Amine OE; Gritli S; ElMay M
    Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1011-1019. PubMed ID: 32468823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
    Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
    Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
    Li T; Li Y
    Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
    Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
    Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW
    J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasopharyngeal carcinoma progression is mediated by EBER-triggered inflammation via the RIG-I pathway.
    Duan Y; Li Z; Cheng S; Chen Y; Zhang L; He J; Liao Q; Yang L; Gong Z; Sun LQ
    Cancer Lett; 2015 May; 361(1):67-74. PubMed ID: 25721089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limb-bud and Heart (LBH) functions as a tumor suppressor of nasopharyngeal carcinoma by inducing G1/S cell cycle arrest.
    Liu Q; Guan X; Lv J; Li X; Wang Y; Li L
    Sci Rep; 2015 Jan; 5():7626. PubMed ID: 25557837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
    Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
    Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
    Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
    Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of adipose triglyceride lipase by EB viral-encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma.
    Zheng S; Matskova L; Zhou X; Xiao X; Huang G; Zhang Z; Ernberg I
    Mol Oncol; 2020 Dec; 14(12):3234-3252. PubMed ID: 33064888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
    Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
    Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.
    Fang CY; Wu CC; Hsu HY; Chuang HY; Huang SY; Tsai CH; Chang Y; Tsao GS; Chen CL; Chen JY
    Int J Mol Sci; 2015 Jan; 16(2):2530-58. PubMed ID: 25625511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
    Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L
    Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
    Wasil LR; Wei L; Chang C; Lan L; Shair KH
    J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.